Planning and Budgeting
Negotiate with deeper insight with budgets developed against industry benchmarks

PORTFOLIO BUDGETING
Create a budget that is over 95% reliable
Quickly design a study budget without the need for financial modeling expertise, advanced Excel skills, or dependence on CRO budgets. Automate pre-RFP budgeting and clinical study scenario modeling needs.
Benefits
SAVE IN DIRECT COSTS
$800,000
Clinical Maestro enabled significant cost savings by automating budgeting and improving negotiation efficiency during clinical trial outsourcing.
CUT OUTSOURCING TIME BY
50%
Automated processes in Clinical Maestro reduced the time from RFP to final budget, accelerating trial timelines.
Inefficient Budgeting and Planning
A West coast-based biotech company faced challenges during the outsourcing of their previous Phase II respiratory clinical trial. Without a clear understanding of a fair budget, they struggled through negotiations, relying heavily on the CRO, and seven months post-RFP, they still lacked a finalized budget or contract. For their next study, the biotech sought to avoid similar issues and streamline the outsourcing process. Determined to enhance their budget creation and outsourcing, they aimed to gain more control over the RFP process. The company wanted a solution that would provide financial clarity, enable effective negotiation, and improve the overall efficiency of their clinical trial outsourcing. After their previous experience, they were open to adopting new technologies and approaches to prevent costly delays and to get better value from the CRO bids.
PORTFOLIO Automates Budgeting Processes
To overcome these challenges, the biotech turned to Strategikon Pharma’s Clinical Maestro® platform. This platform offered them the tools to create study models using industry benchmarks and automate their RFP process. The Sponsor created an RFP directly in the system, which allowed them to invite CROs to bid in both “bid-to-spec” and “bid-to-expertise” scenarios. Clinical Maestro enabled comprehensive analysis of bids, providing clear side-by-side comparisons of CROs’ strategies and assumptions. This transparency, combined with the system’s automation capabilities, streamlined the entire process—from setting up study models to managing bids and contracts—significantly improving due diligence and negotiation efficiency.
Faster Outsourcing, Reduced Costs
Using Clinical Maestro, the biotech cut their outsourcing time by four months and saved $800,000 in direct costs. The time from RFP to final budget was twice as fast compared to traditional methods. The company was able to thoroughly vet CRO bids, ensuring fair market value and creating greater negotiation leverage. As a result, they experienced 25x ROI within just four months of using the platform.

Improved Budgeting with PORTFOLIO
The biotech achieved a significant return on investment and process efficiency using Clinical Maestro. The platform enabled faster decision-making, effective cost control, and improved vendor transparency. With these results, the company plans to use Clinical Maestro for their next three studies, confident in its ability to solve ongoing outsourcing challenges.
See how one West – coast biotech did it:
Benefits
SAVE IN DIRECT COSTS
$800,000
Clinical Maestro enabled significant cost savings by automating budgeting and improving negotiation efficiency during clinical trial outsourcing.
CUT OUTSOURCING TIME BY
50%
Automated processes in Clinical Maestro reduced the time from RFP to final budget, accelerating trial timelines.
See how one West – coast biotech did it:
RESOURCES
Explore Expert Insights and Resources for Clinical Excellence

Webinars
Biopharmaceutical companies and the CROs have been struggling with achieving greater visibility in their clinical vendor portfolios and the challenges are only getting bigger, impacting compliance to vendor oversight regulations and heightening vendor portfolio risks. The intense M&A and rebranding activity in the clinical marketplace, the emergence of new e-clinical service categories and the shrinking of the dedicated vendor management resource pool have further compounded the pain points, and the need for sustainable solutions. In the age of tech-enabled procurement, the time has come to replace the notorious Excel “vendor tracker” with a central hub for vendor performance management and bring visibility and oversight compliance to clinical trial management!

Blogs
Effective vendor governance is essential to ensure operational success, cost efficiency, and regulatory compliance.

Case Studies
DEMO
Request a demo
Discover how Strategikon’s advanced solutions can streamline your clinical trial operations. Request a personalized demo to explore how our tools transform budgeting, vendor management, and outsourcing efficiency for pharma and biotech.